In conclusion, this nested case-control study provides evidence that preoperative, but not postoperative IGF-I and IGFBP-3 levels provide independent prognostic information and influence breast cancer recurrence, justifying confirmatory studies with larger numbers of subjects. The gene discussed is IGFBP3; the disease is breast cancer.